Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2525 of 2529 entries
View as:

Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT05335876 Org: User:
Start: 12/19/22 End: 06/26/30 Due: 06/26/31

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00411528 Org: User:
Start: 09/30/06 End: 09/30/12 Due: 09/30/13

Managed Access Programs for LEE011, Ribociclib

Phase: N/A Priority: Normal
NCT ID: NCT05038631 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00375648 Org: User:
Start: 06/30/05 End: - Due: -

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT04489433 Org: User:
Start: - End: - Due: -

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT03827798 Org: User:
Start: 02/27/19 End: 12/10/26 Due: 12/10/27

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Phase: N/A Priority: Normal
NCT ID: NCT00045942 Org: User:
Start: 01/30/02 End: 03/27/08 Due: 03/27/09

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

Phase: N/A Priority: Normal
NCT ID: NCT02187783 Org: User:
Start: 08/25/14 End: 01/17/18 Due: 01/17/19

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Phase: N/A Priority: Normal
NCT ID: NCT00471497 Org: User:
Start: 07/31/07 End: 08/21/19 Due: 08/21/20

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

Phase: N/A Priority: Normal
NCT ID: NCT06247995 Org: User:
Start: 08/14/24 End: 09/09/31 Due: 09/09/32

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03570892 Org: User:
Start: 05/07/19 End: 02/11/26 Due: 02/11/27

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Phase: N/A Priority: Normal
NCT ID: NCT05142696 Org: User:
Start: 07/13/22 End: 03/23/29 Due: 03/23/30

Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00448396 Org: User:
Start: 03/31/07 End: - Due: -

A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01613976 Org: User:
Start: 08/31/12 End: 05/31/14 Due: 05/31/15

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01426789 Org: User:
Start: 08/31/11 End: 02/28/14 Due: 02/28/15

A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT05344469 Org: User:
Start: 05/10/22 End: 12/31/26 Due: 12/31/27

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06236061 Org: User:
Start: 04/08/24 End: 12/25/25 Due: 12/25/26

Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00225979 Org: User:
Start: 11/30/02 End: 03/31/05 Due: 03/31/06

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT01110668 Org: User:
Start: 09/30/08 End: 09/30/11 Due: 09/30/12

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00877149 Org: User:
Start: 03/31/09 End: - Due: -

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00900731 Org: User:
Start: 06/30/09 End: 03/31/10 Due: 03/31/11

A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

Phase: N/A Priority: Normal
NCT ID: NCT06854341 Org: User:
Start: 02/09/24 End: 08/27/24 Due: 08/27/25

A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00503451 Org: User:
Start: 09/30/07 End: - Due: -

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02961218 Org: User:
Start: 04/05/17 End: 04/27/20 Due: 04/27/21

A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02705963 Org: User:
Start: 10/20/16 End: 08/29/19 Due: 08/29/20